Bi Asset Management Fondsmaeglerselskab A Dexcom Inc Transaction History

Bi Asset Management Fondsmaeglerselskab A

$6.11 Billion
Q2 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Dexcom Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 23,311 shares of DXCM stock, worth $1.62 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

23,311

Previous 10,620 119.5%

Holding current value

$1.62 Million

Previous $1.47 Million 79.43%

% of portfolio

0.04%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $1.4 Million - $1.78 Million	12,691 Added 119.5%	23,311 $2.64 Million
Q1 2024 May 03, 2024	BUY	$114.22 - $140.1 $358,308 - $439,493	3,137 Added 41.92%	10,620 $1.47 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $1.1 Million - $1.8 Million	-14,524 Reduced 66.0%	7,483 $929,000
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $1.21 Million - $1.95 Million	14,116 Added 178.89%	22,007 $2.05 Million
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $5.57 Million - $6.49 Million	-49,526 Reduced 86.26%	7,891 $1.01 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $4.43 Million - $5.23 Million	42,573 Added 286.8%	57,417 $6.67 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $23,199 - $33,488	-273 Reduced 1.81%	14,844 $1.68 Million
Q3 2022 Nov 07, 2022	BUY	$76.35 - $94.18 $106,660 - $131,569	1,397 Added 10.18%	15,117 $1.22 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $816,627 - $1.6 Million	12,011 Added 702.81%	13,720 $1.02 Million
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $124,091 - $171,733	-1,319 Reduced 43.56%	1,709 $874,000
Q4 2021 Feb 02, 2022	SELL	$129.87 - $162.82 $799,349 - $1 Million	-6,155 Reduced 67.03%	3,028 $1.63 Million
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $565,563 - $758,854	5,300 Added 136.49%	9,183 $5.02 Million
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $95,727 - $118,251	-1,129 Reduced 22.53%	3,883 $1.4 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $451,074 - $604,323	-5,783 Reduced 53.57%	5,012 $1.85 Million
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $199,424 - $235,839	2,088 Added 23.98%	10,795 $4.45 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $258,993 - $435,264	4,132 Added 90.32%	8,707 $3.53 Million
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $127,599 - $201,932	-2,670 Reduced 36.85%	4,575 $1.23 Million
Q4 2019 Mar 19, 2020	BUY	$36.62 - $57.29 $228,911 - $358,119	6,251 Added 628.87%	7,245 $1.59 Million
Q3 2019 Mar 19, 2020	SELL	$35.53 - $43.8 $12,186 - $15,023	-343 Reduced 25.65%	994 $148,000
Q2 2019 Mar 19, 2020	BUY	$27.84 - $38.92 $37,222 - $52,036	1,337 New	1,337 $200,000

Others Institutions Holding DXCM

# of Institutions

1,058

Shares Held

361M

Call Options Held

4.11M

Put Options Held

3.63M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Dexcom Inc Transaction History